check_circleStudy Completed
Erectile Dysfunction
Bayer Identifier:
100540
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Evaluation of efficacy and safety of Vardenafil in patients with erectile dysfunction and type 1 diabetes
Trial purpose
Asses efficacy of Vardenafil in patients with type 1 diabetes and erectile dysfunction
Key Participants Requirements
Sex
MaleAge
18 YearsTrial summary
Enrollment Goal
318Trial Dates
February 2003 - January 2004Phase
Phase 4Could I Receive a placebo
YesProducts
Levitra (Vardenafil, BAY38-9456)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Germany |
Primary Outcome
- Sexual Encounter Profile Question 2date_rangeTime Frame:12 weeksenhanced_encryptionnoSafety Issue:
- Sexual Encounter Profile Question 3date_rangeTime Frame:12 weeksenhanced_encryptionnoSafety Issue:
Secondary Outcome
- International Index of Erectile Function - Erectile Function Domaindate_rangeTime Frame:12 weeksenhanced_encryptionnoSafety Issue:
- Safety and Tolerabilitydate_rangeTime Frame:12 weeksenhanced_encryptionyesSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
TreatmentAllocation
RandomizedBlinding
Double BlindAssignment
Parallel AssignmentTrial Arms
2